Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devanand Sarkar

Showing results (11-20 of 289) with videos related to

Pageof 29
Sort By:
Cancers|May 21, 2020
Non-Coding RNAs: Regulating Disease Progression and Therapy Resistance in Hepatocellular CarcinomaDebashri Manna, Devanand Sarkar
Advances in Cancer Research|February 13, 2021
PrefaceDevanand Sarkar, Paul B Fisher
Cancers|August 31, 2019
Current Status of Gene Therapy in Hepatocellular CarcinomaSaranya Chidambaranathan Reghupaty, Devanand Sarkar
Advances in Cancer Research|July 30, 2013
AEG-1/MTDH/LYRIC: clinical significanceDevanand Sarkar, Paul B Fisher
Cancers|December 17, 2024
Resistance to Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma (HCC): Clinical Implications and Potential Strategies to Overcome the ResistanceAli Gawi Ermi, Devanand Sarkar
Cancer Letters|June 28, 2005
Molecular mechanisms of aging-associated inflammationDevanand Sarkar, Paul B Fisher
Pharmacology & Therapeutics|May 31, 2006
Polynucleotide phosphorylase: an evolutionary conserved gene with an expanding repertoire of functionsDevanand Sarkar, Paul B Fisher
Advances in Cancer Research|July 30, 2013
Advances in Cancer Research. AEG-1/MTDH/LYRIC implicated in multiple human cancers. PrefaceDevanand Sarkar, Paul B Fisher
Cell Cycle (Georgetown, Tex.)|May 12, 2006
Human polynucleotide phosphorylase (hPNPase old-35): an RNA degradation enzyme with pleiotrophic biological effectsDevanand Sarkar, Paul B Fisher
Cancer Biology & Therapy|June 16, 2006
Regulation of Myc function by ARF: checkpoint for Myc-induced oncogenesisDevanand Sarkar, Paul B Fisher
Pageof 29

Showing results (11-20 of 289) with videos related to

Sort By:
Pageof 29
Cancers|May 21, 2020
Non-Coding RNAs: Regulating Disease Progression and Therapy Resistance in Hepatocellular CarcinomaDebashri Manna, Devanand Sarkar
Advances in Cancer Research|February 13, 2021
PrefaceDevanand Sarkar, Paul B Fisher
Cancers|August 31, 2019
Current Status of Gene Therapy in Hepatocellular CarcinomaSaranya Chidambaranathan Reghupaty, Devanand Sarkar
Advances in Cancer Research|July 30, 2013
AEG-1/MTDH/LYRIC: clinical significanceDevanand Sarkar, Paul B Fisher
Cancers|December 17, 2024
Resistance to Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma (HCC): Clinical Implications and Potential Strategies to Overcome the ResistanceAli Gawi Ermi, Devanand Sarkar
Cancer Letters|June 28, 2005
Molecular mechanisms of aging-associated inflammationDevanand Sarkar, Paul B Fisher
Pharmacology & Therapeutics|May 31, 2006
Polynucleotide phosphorylase: an evolutionary conserved gene with an expanding repertoire of functionsDevanand Sarkar, Paul B Fisher
Advances in Cancer Research|July 30, 2013
Advances in Cancer Research. AEG-1/MTDH/LYRIC implicated in multiple human cancers. PrefaceDevanand Sarkar, Paul B Fisher
Cell Cycle (Georgetown, Tex.)|May 12, 2006
Human polynucleotide phosphorylase (hPNPase old-35): an RNA degradation enzyme with pleiotrophic biological effectsDevanand Sarkar, Paul B Fisher
Cancer Biology & Therapy|June 16, 2006
Regulation of Myc function by ARF: checkpoint for Myc-induced oncogenesisDevanand Sarkar, Paul B Fisher
Pageof 29